Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Price:
15.9 AUD
5.02%
Market Closed
Updated:
Jun 1, 2024
Clinuvel Pharmaceuticals Ltd
Total Current Assets
|
Clinuvel Pharmaceuticals Ltd
Total Current Assets Peer Comparison
Comparables:
IMM
MSB
CSL
TLX
PYC
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Current Assets
AU$201.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
35%
|
CAGR 10-Years
32%
|
|
|
Immutep Ltd
ASX:IMM
|
Total Current Assets
AU$113m
|
CAGR 3-Years
22%
|
CAGR 5-Years
30%
|
CAGR 10-Years
14%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Total Current Assets
$85.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Total Current Assets
$10.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Current Assets
AU$224.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Current Assets
AU$34.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
17%
|
See Also
What is Clinuvel Pharmaceuticals Ltd's Total Current Assets?
Total Current Assets
201.5m
AUD
201.5m
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Total Current Assets amounts to 201.5m AUD.
What is Clinuvel Pharmaceuticals Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
32%
32%
Over the last year, the Total Current Assets growth was 28%. The average annual Total Current Assets growth rates for Clinuvel Pharmaceuticals Ltd have been 36% over the past three years , 35% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
